Choosing the Right Injection Sites: Where Can You Give Wegovy Shot?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work by delivering medication through subcutaneous tissue—the fatty layer beneath your skin. Rotating injection sites is critical because repeated use of the same area can cause lipohypertrophy, a thickening of fatty tissue that interferes with medication absorption and treatment consistency.

Approved Semaglutide Injection Site Locations

The abdomen is the most commonly recommended injection site for semaglutide, as it provides predictable absorption and allows for easy self-administration. The upper outer thigh is also approved and offers a practical alternative, especially when traveling or in social settings where privacy is limited. The back of the upper arm (triceps area) is the third approved location, though many patients find this site more difficult to access without assistance.

Clinical guidance specifies that injections should be placed at least 2 inches away from the navel on the abdomen, and avoid areas with scars, bruises, or existing skin conditions. For the thigh, the injection point should be on the outer portion where you have adequate subcutaneous tissue. The upper arm site requires careful selection to ensure sufficient fatty tissue depth for proper subcutaneous delivery.

How to Rotate Injection Sites Safely

Site rotation prevents lipohypertrophy and ensures consistent medication absorption across treatment weeks. A practical rotation strategy involves using one primary location (such as the abdomen) for each weekly injection, then shifting to a different area the following week. Within each location, you should vary the specific injection point—for example, if using the abdomen, alternate between the left and right sides, and space injection points approximately 1 to 1.5 inches apart.

Maintaining a simple rotation log—either digital or written—helps prevent injecting the same spot twice in close succession. PlexusDx patients receiving compounded semaglutide should follow the same evidence-based rotation practices as brand-name alternatives, as the medication's pharmacology and tissue interaction remain consistent. Proper rotation also reduces the risk of injection-site reactions and maintains the medication's efficacy throughout your treatment program.

Understanding Subcutaneous Injection Depth

Semaglutide must be injected into subcutaneous tissue, the layer of fat beneath the dermis, not into muscle or too superficially in the skin itself. The standard needle length for semaglutide auto-injectors and pre-filled pens is typically 4–6 millimeters, which is designed to reach subcutaneous tissue in most patients. Injecting too deeply risks hitting muscle, which can cause discomfort and unpredictable absorption rates, while injecting too superficially may deposit the medication in the dermis rather than subcutaneous fat.

If you have very lean physiology with minimal subcutaneous tissue, your PlexusDx healthcare provider can discuss whether an alternative injection site or technique adjustment may be appropriate. Holding the skin taut during injection and allowing a 5-second pause before withdrawing the needle helps ensure medication dispersal into the correct tissue layer and reduces backflow.

Managing Injection Site Reactions and Comfort

Some patients experience mild redness, swelling, or bruising at injection sites, particularly during the first few weeks of treatment. These reactions typically resolve within a few hours to days and are not a sign that the medication is ineffective or unsafe. Applying gentle ice before injection can numb the area and reduce initial discomfort, while warm compresses after injection may help minimize bruising and inflammation.

Rotating sites actively reduces the likelihood of these reactions because no single area receives repeated injections within a short time frame. If redness, warmth, or swelling persists beyond 48 hours, or if you develop signs of infection (pus, fever, or spreading erythema), contact your PlexusDx care team immediately. Proper technique—including allowing the injection site to air-dry after an alcohol swab and using a fresh needle for each injection—further minimizes the risk of site complications.

PlexusDx Semaglutide Injection: Personalized Dosing and Support

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are formulated by licensed 503A compounding pharmacies to meet strict quality standards. Your dose may need to go up over time as your body adjusts, but your price won't—PlexusDx maintains flat pricing across all dose levels, making consistent, long-term treatment financially predictable. Every patient receives detailed injection training and ongoing support to ensure proper technique and site rotation from the outset.

The Precision Peptide Genetic Test, available as a $99 add-on after your first month, can reveal how your specific genetic variants influence GLP-1 receptor sensitivity and other metabolic pathways. This personalized insight helps your PlexusDx provider optimize your semaglutide protocol and anticipate your individual response pattern. PlexusDx serves all 50 states with no insurance requirement, and semaglutide is HSA/FSA eligible for additional cost savings.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No—repeatedly injecting the same area increases lipohypertrophy risk and reduces medication absorption consistency. Rotate between your three approved zones (abdomen, thigh, upper arm) and vary specific injection points within each zone. PlexusDx patients receive detailed rotation guidance to maximize treatment effectiveness and minimize site complications.

What is lipohypertrophy and why does site rotation prevent it?

Lipohypertrophy is an abnormal thickening of subcutaneous fat caused by repeated trauma and needle insertion in the same area. This thickening creates a fibrous nodule that absorbs insulin and GLP-1 medications poorly, causing dose response to become unpredictable. Rotating sites allows each area to heal and regenerate normal tissue architecture between injections.

How deep should I push the needle for semaglutide?

Standard semaglutide needles (4–6mm) are designed to reach subcutaneous tissue automatically when inserted at a 90-degree angle. You should feel gentle resistance but not pain; if you hit muscle or experience sharp discomfort, your angle or tissue depth may need adjustment. PlexusDx care staff can review your injection technique during your initial onboarding call.

What should I do if I develop a bruise or swelling at the injection site?

Mild bruising and swelling are common and typically resolve within 24–48 hours without treatment. Apply ice before injection and gentle warmth afterward to minimize these reactions. If redness, warmth, or swelling persists beyond 48 hours or shows signs of infection, contact your PlexusDx provider immediately for assessment.

Does the Precision Peptide Genetic Test help optimize my injection strategy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I inject semaglutide through clothing?

No—inject only through clean, bare skin. Clothing can introduce bacteria, reduce needle precision, and interfere with proper subcutaneous placement. Always prepare your injection site with an alcohol swab, allow it to air-dry, and ensure you have a clear view of the injection area.

Related Reading

• Injection Wegovy
• Mounjaro Injection Sites
• Wegovy Shot
• Wegovy Injection Site

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.